Virotech Pharmaceutical

Company Drug

Guangzhou Virotech’s Oncolytic Virus M1 Receives Tacit Clinical Approval from NMPA

Fineline Cube Dec 4, 2024

Guangzhou Virotech Pharmaceutical Co., Ltd., a China-based pharmaceutical company, has announced receiving tacit clinical approval...

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link

Company Drug

Leqvio Gets NMPA Nod for Monotherapy in China Hypercholesterolemia

Company Deals

Apeloa Partners with MindRank on AI Drug Development Platform

Policy / Regulatory

China Drug Administration Implementation Regulations Set for May 2026 Launch